Gene expression profiles as prognostic factors in patients with multiple myeloma treated with conventional versus novel agents in correlation with outcome

被引：0
|
作者：
Broyl, Annemiek [1 ]
Hose, Dirk [3 ]
De Knegt, Yvonne [1 ]
Lokhorst, Henk [2 ]
Goldschmidt, Hartmut
Van Duin, Mark [1 ]
Sonneveld, Pieter [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Univ Heidelberg, Heidelberg, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3173.3173
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3173
引用
收藏
页码：932A / 932A
页数：1
相关论文
共 50 条
  • [31] Comparison Of Conventional, FISH and GEP Prognostic Factors In Multiple Myeloma: Introducing a Novel Risk Stratification
    Kuiper, Rowan
    van Vliet, Martin
    Broyl, Annemiek
    de Knegt, Yvonne
    van der Holt, Bronno
    el Jarari, Laila
    Mulligan, George
    Gregory, Walter
    Morgan, Gareth J.
    Goldschmidt, Hartmut
    Bertsch, Uta
    Lokhorst, Henk
    van Duin, Mark
    van Beers, Erik
    Sonneveld, Pieter
    BLOOD, 2013, 122 (21)
  • [32] Characterization of gene expression profiles of plasma cells in patients with multiple myeloma.
    Ortega, Manoela M.
    Cunha, Anderson F.
    Alberquerque, Dulcineia M.
    Duarte, Adriana S. S.
    De Souza, Carmino
    Lorand-Metze, Irene
    Costa, Fernando F.
    Lima, Carmen S. P.
    BLOOD, 2006, 108 (11) : 360B - 360B
  • [33] Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles
    Li, Yingxiang
    Wang, Xujun
    Zheng, Haiyang
    Wang, Chengyang
    Minvielle, Stephane
    Magrangeas, Florence
    Avet-Loiseau, Herve
    Shah, Parantu K.
    Zhang, Yong
    Munshi, Nikhil C.
    Li, Cheng
    PLOS ONE, 2013, 8 (03):
  • [34] Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials
    Chen, Yan-Ting
    Valent, Erik T.
    van Beers, Erik H.
    Kuiper, Rowan
    Oliva, Stefania
    Haferlach, Torsten
    Chng, Wee-Joo
    van Vliet, Martin H.
    Sonneveld, Pieter
    Larocca, Alessandra
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (01) : 127 - 134
  • [35] High Prevalence Of Extramedullary Relapse In Patients With Multiple Myeloma Treated With Novel Biological Agents
    Mangiacavalli, Silvia
    Pompa, Alessandra
    Pascutto, Cristiana
    Ferretti, Virginia
    Pochintesta, Lara
    Cocito, Federica
    Varettoni, Marzia
    Lazzarino, Mario
    Cazzola, Mario
    Corso, Alessandro
    BLOOD, 2013, 122 (21)
  • [36] IMMUNOPHENOTYPIC REMISSIONS CAN BE ACHIEVED IN ELDERLY MULTIPLE MYELOMA PATIENTS TREATED WITH NOVEL AGENTS
    Paiva, Bruno
    Vidriales, Maria-Belen
    Montalban, Maria A.
    Martinez, Joaquin
    Fernandez-Redondo, Elena
    Mateos, Maria-Victoria
    Gutierrez, Norma C.
    Lopez-Corral, Lucia
    Perez, Jose J.
    Martin, Alejandro
    Terol, Maria J.
    Gonzalez, Yolanda
    Echebeste, Maria A.
    Hernandez, Jose
    De Arriba, Felipe
    De Paz, Raquel
    Blade, Joan
    Lahuerta, Juan J.
    Orfao, Alberto
    San Miguel, Jesus F.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 454 - 454
  • [37] Gene expression profiling and clinical outcome in melanoma: In search of novel prognostic factors
    Winnepenninckx, Veronique
    van den Oord, Joost J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (11) : 1611 - 1631
  • [38] Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS
    Qian, Xiaozhong
    Dimopoulos, Meletios A.
    Amatangelo, Michael
    Bjorklund, Chad
    Towfic, Fadi
    Flynt, Erin
    Weisel, Katja C.
    Ocio, Enrique M.
    Yu, Xin
    Peluso, Teresa
    Sternas, Lars
    Zaki, Mohamed
    Moreau, Philippe
    Thakurta, Anjan
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 462 - 470
  • [39] Prognostic factors and outcome of older patients with symptomatic multiple myeloma: A study of the Greek Myeloma Study Group (GMSG).
    Anagnostopoulos, A
    Gika, D
    Symeonidis, A
    Zervas, K
    Pouli, A
    Repoussis, P
    Grigoraki, V
    Anagnostopoulos, N
    Maniatis, AG
    Dimopoulos, MA
    BLOOD, 2004, 104 (11) : 294B - 294B
  • [40] Study of prognostic factors in multiple myeloma:: A report on 203 patients including 60 intensively treated patients
    Facon, T
    Mary, JY
    Zandecki, M
    Mathiot, C
    Laï, JL
    Faucompré, JL
    Hennache, B
    Stalnikiewicz, L
    Jouet, JP
    Bauters, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 9 - 9
12345